KLOW is a compounded peptide blend designed for research and performance recovery applications. The formulation typically includes:
- BPC 157 – 10 mg
A synthetic pentadecapeptide derived from a naturally occurring protein in human gastric juice. - GHK-Cu – 50 mg
A copper-binding tripeptide composed of glycine, histidine, and lysine, known for its role in skin and tissue regeneration. - TB500 – 10 mg
A synthetic peptide fragment of Thymosin Beta-4, responsible for promoting cell migration and tissue repair. - KPV 10 mg
2. Benefits:
Each peptide in the GLOW formulation has distinct and complementary biological effects, particularly in the areas of recovery, regeneration, and inflammation modulation.
BPC 157:
- Promotes healing of soft tissues, including muscles, tendons, ligaments, and the gastrointestinal tract.
- Exhibits anti-inflammatory properties by modulating nitric oxide and cytokine pathways.
- Supports angiogenesis (formation of new blood vessels), which improves blood flow to damaged areas.
- May help protect the gut lining, based on animal models.
GHK-Cu:
- Enhances collagen production and wound healing in skin and connective tissue.
- Reduces oxidative stress and inflammation by modulating gene expression involved in tissue repair.
- May support hair growth and skin rejuvenation in cosmetic applications.
- Promotes blood vessel growth (angiogenesis) and helps maintain extracellular matrix integrity.
TB500:
- Encourages cell migration, crucial for rapid tissue repair.
- Reduces inflammation and oxidative stress in injured tissues.
- Accelerates recovery of muscles, tendons, and ligaments, particularly in overuse or trauma-related injuries.
- Supports neural regeneration and may aid in central nervous system recovery (preclinical data).
Note: While individual peptides have supportive preclinical and limited human research, combined use (as in GLOW) is experimental and not yet evaluated in large-scale clinical trials.
Reviews
There are no reviews yet.